Industry News

Genzyme Corp. intends to build a recombinant protein manufacturing plant in Framingham, Ma. The 300,000-sf facility is estimated to be running by 2004. In Waterford, Ireland, Genzyme has purchased a 120,000-sf plant for manufacturing Renagel, with a multiproduct manufacturing facility planned nearby.

Emmanuel College in Boston has partnered with Merck & Co. Inc. on a planned 300,000-sf research center. The Merck-owned facility on Emmanuel's 16-acre campus will foster a relationship between the college's biology students and Merck.   

Emerson College is planning several new developments, including a new residence hall and college center housing additional athletic and student activity space. Adjacent to the Majestic Theatre, Emerson has planned a $30 million, 11-story performance and production center containing offices, classrooms, laboratories, a television studio, an exhibition area, two small theaters, and dressing rooms for the Majestic, which will also be renovated.  

Boston College is undertaking several campus projects, including a $90 million renovation of the Higgins Science Building estimated to reach completion in fall of 2002. Construction has begun on a $36 million, 156,000-sf office facility on the lower campus, with plans for a $120 million development of three interconnected buildings (housing classrooms, offices, student services, and an auditorium) to follow.

Biogen Inc. is planning to build its first European manufacturing facility on 60 acres purchased in the Municipality of Hillerod, Denmark. With an option to buy an additional 36 acres, the Cambridge, Ma.-based firm has allotted $350 million to develop the project.